BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31952535)

  • 21. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.
    Choi KH; Song YB; Lee JM; Lee SY; Park TK; Yang JH; Choi JH; Choi SH; Gwon HC; Hahn JY
    JACC Cardiovasc Interv; 2019 Apr; 12(7):607-620. PubMed ID: 30878474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.
    Capodanno D; Gargiulo G; Buccheri S; Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Leon MB; Moses JW; Fajadet J; Lefèvre T; Morice MC; Erglis A; Alfieri O; Serruys PW; Colombo A; Tamburino C;
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2280-2288. PubMed ID: 27884354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R
    Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    Lee CH; Choi SW; Jun SW; Hwang J; Kim IC; Cho YK; Park HS; Yoon HJ; Kim H; Nam CW; Han S; Kim KB; Hur SH
    PLoS One; 2020; 15(6):e0234362. PubMed ID: 32520973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
    van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
    Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan.
    Akita K; Inohara T; Yamaji K; Kohsaka S; Numasawa Y; Ishii H; Amano T; Kadota K; Nakamura M; Maekawa Y
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):231-238. PubMed ID: 31593213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
    Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
    JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry CathPCI Registry.
    Beohar N; Kaltenbach LA; Wojdyla D; Pineda AM; Rao SV; Stone GW; Leon MB; Sanghvi KA; Moses JW; Kirtane AJ
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008239. PubMed ID: 31973557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy.
    Bergman S; Mohammad MA; James SK; Angerås O; Wagner H; Jensen J; Scherstén F; Fröbert O; Koul S; Erlinge D
    J Am Heart Assoc; 2021 Sep; 10(18):e022984. PubMed ID: 34514849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention.
    Mortazavi BJ; Bucholz EM; Desai NR; Huang C; Curtis JP; Masoudi FA; Shaw RE; Negahban SN; Krumholz HM
    JAMA Netw Open; 2019 Jul; 2(7):e196835. PubMed ID: 31290991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
    Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT
    EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).
    Brennan JM; Curtis JP; Dai D; Fitzgerald S; Khandelwal AK; Spertus JA; Rao SV; Singh M; Shaw RE; Ho KK; Krone RJ; Weintraub WS; Weaver WD; Peterson ED;
    JACC Cardiovasc Interv; 2013 Aug; 6(8):790-9. PubMed ID: 23968699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.
    Valle JA; Tamez H; Abbott JD; Moussa ID; Messenger JC; Waldo SW; Kennedy KF; Masoudi FA; Yeh RW
    JAMA Cardiol; 2019 Feb; 4(2):100-109. PubMed ID: 30601910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.